Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("BUGELSKI, P. J")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 34

  • Page / 2
Export

Selection :

  • and

Sequential histochemical staining for resident and recruited macrophagesBUGELSKI, P. J.Journal of leukocyte biology. 1985, Vol 38, Num 6, pp 687-696, issn 0741-5400Article

Characterization of CD4-gp120 activation intermediates during human immunodeficiency virus type 1 syncytium formationHART, T. K; TRUNEH, A; BUGELSKI, P. J et al.AIDS research and human retroviruses. 1996, Vol 12, Num 14, pp 1305-1313, issn 0889-2229Article

Biochemical and functional analysis of rat bronchoalveolar macrophages containing chemically induced phospholipid inclusionsWAITES, C. R; BUGELSKI, P. J; BADGER, A. M et al.Toxicology and applied pharmacology. 1995, Vol 130, Num 2, pp 316-321, issn 0041-008XArticle

Relationships between antibodies against human soluble complement receptor 1 (hsCR1) from various speciesRUGGIERI, E. V; BUGELSKI, P. J; KAPLAN, J. M et al.Journal of clinical immunology. 1996, Vol 16, Num 2, pp 97-106, issn 0271-9142Article

Tumor necrosis factor-α mediates endotoxin-induced lung injury in platelet activating factor-primed ratsRABINOVICI, R; BUGELSKI, P. J; ESSER, K. M et al.The Journal of pharmacology and experimental therapeutics. 1993, Vol 267, Num 3, pp 1550-1557, issn 0022-3565Article

Induction of suppressor cell activity in vivo and suppression of lymphoproliferative responses in vitro by SK&F 105685 in the dogTHIEM, P. A; KAPLAN, J. M; BUGELSKI, P. J et al.Immunopharmacology (New York). 1992, Vol 23, Num 2, pp 67-74, issn 0162-3109Article

A new cytochemical method for ultrastructural detection of liposomes in tissues in vivoBUGELSKI, P. J; GENNARO, D. E; POSTE, G et al.The Journal of histochemistry and cytochemistry. 1989, Vol 37, Num 6, pp 843-851, issn 0022-1554, 9 p.Article

Influence of selective endoperoxide/thromboxane A2 receptor antagonism with sulotroban on lysis time and reocclusion rate after tissue plasminogen activator-induced coronary thrombolysis in the dogSHEBUSKI, R. J; SMITH, J. M. JR; STORER, B. L et al.The Journal of pharmacology and experimental therapeutics. 1988, Vol 246, Num 2, pp 790-796, issn 0022-3565Article

Practical aspects of including functional endpoints in developmental toxicity studies. Case study: immune function in HuCD4 transgenic mice exposed to anti-CD4 MAb in uteroHERZYK, D. J; BUGELSKI, P. J; HART, T. K et al.Human & experimental toxicology. 2002, Vol 21, Num 9-10, pp 507-512, issn 0960-3271, 6 p.Conference Paper

Physicochemical dissociation of CD4-mediated syncytium formation and shedding of human immunodeficiency virus type 1 gp120YUNG-KANG FU; HART, T. K; JONAK, Z. L et al.Journal of virology. 1993, Vol 67, Num 7, pp 3818-3825, issn 0022-538XArticle

Effect of a human immunodeficiency virus protease inhibitor on human monocyte functionBUGELSKI, P. J; KAPLAN, J. M; HART, T. K et al.AIDS research and human retroviruses. 1992, Vol 8, Num 12, pp 1951-1958, issn 0889-2229Article

Macrophage content of spontaneous metastases at different stages of growthBUGELSKI, P. J; CORWIN, S. P; NORTH, S. M et al.Cancer research (Baltimore). 1987, Vol 47, Num 15, pp 4141-4145, issn 0008-5472Article

Selective inhibition of phospholipases by atiprimod, a macrophage targeting antiarthritic compoundHANDLER, J. A; BADGER, A; GENELL, C. A et al.Toxicology and applied pharmacology. 1999, Vol 159, Num 1, pp 9-17, issn 0041-008XArticle

Strong association of Simian immunodeficiency virus (SIVagm) envelope glycoprotein heterodimers : possible role in receptor-mediated activationALLAN, J. S; WHITEHEAD, E. M; STROUT, K et al.AIDS research and human retroviruses. 1992, Vol 8, Num 12, pp 2011-2020, issn 0889-2229Article

Inhibition of lymphoproliferative responses by SK&F 105685, a novel anti-arthritic agentKAPLAN, J. M; BADGER, A. M; RUGGIERI, E. V et al.Journal of clinical & laboratory immunology. 1991, Vol 36, Num 4, pp 49-58, issn 0141-2760Article

Recombinant human soluble CD4 does not inhibit immune function in cynomolgus monkeysBUGELSKI, P. J; THIEM, P. A; TRUNEH, A et al.Toxicologic pathology. 1991, Vol 19, Num 4, pp 580-588, issn 0192-6233, 2Conference Paper

Internalization of recombinant tissue-type plasminogen activator by isolated rat hepatocytes is via coated pitsMARKS, G. J; HART, T. K; RUSH, G. F et al.Thrombosis and haemostasis. 1990, Vol 63, Num 2, pp 251-258, issn 0340-6245, 8 p.Article

Temporal relation between neutrophil accumulation and myocardial reperfusion injurySMITH, E. F. III; EGAN, J. W; BUGELSKI, P. J et al.American journal of physiology. Heart and circulatory physiology. 1988, Vol 24, Num 5, pp H1060-H1068, issn 0363-6135Article

The mechanism of acute cytotoxicity of triethylphosphine gold(I) complexes. I: Characterization of triethylphosphine gold chloride-induced biochemical and morphological changes in isolated hepatocytesRUSH, G. F; SMITH, P. F; ALBERTS, D. W et al.Toxicology and applied pharmacology. 1987, Vol 90, Num 3, pp 377-390, issn 0041-008XArticle

Chemometric strategies for normalisation of gene expression data obtained from cDNA microarraysWU, W; WILDSMITH, S. E; WINKLEY, A. J et al.Analytica chimica acta. 2001, Vol 446, Num 1-2, pp 451-466, issn 0003-2670Conference Paper

Repeated acetaminophen dosing in rats : adaptation of hepatic antioxidant systemO'BRIEN, P. J; SLAUGHTER, M. R; SWAIN, A et al.Human & experimental toxicology. 2000, Vol 19, Num 5, pp 277-283, issn 0960-3271Article

Preclinical development of keliximab, a Primatizedanti-CD4 monoclonal antibody, in human CD4 transgenic mice : characterization of the model and safety studiesBUGELSKI, P. J; HERZYK, D. J; MACIA, R. A et al.Human & experimental toxicology. 2000, Vol 19, Num 4, pp 230-243, issn 0960-3271Conference Paper

Single-organism model of host defense against infection : A novel immunotoxicologic approach to evaluate immunomodulatory drugsHERZYK, D. J; RUGGIERI, E. V; CUNNINGHAM, L et al.Toxicologic pathology. 1997, Vol 25, Num 4, pp 351-362, issn 0192-6233Article

Effect of TNFα production inhibitors BRL 61063 and pentoxifylline on the response of rats to poly I:CKAPLAN, J. M; HERZYK, D. J; RUGGIERI, E. V et al.Toxicology (Amsterdam). 1995, Vol 95, Num 1-3, pp 187-196, issn 0300-483XArticle

Biological, molecular, and structural analysis of a cytopathic variant from a molecularly cloned simian immunodeficiency virusLABRANCHE, C. C; SAUTER, M. M; HAGGARTY, B. S et al.Journal of virology. 1994, Vol 68, Num 9, pp 5509-5522, issn 0022-538XArticle

  • Page / 2